GlycoMimetics Inc (NASDAQ:GLYC)

15.56
BATS BZX Real-Time Price
As of 10:22am ET
 -0.30 / -1.89%
Today’s Change
10.06
Today|||52-Week Range
26.05
-7.33%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close15.86
Today’s open16.06
Day’s range15.39 - 16.12
Volume6,897
Average volume (3 months)714,615
Market cap$815.5M
Data as of 10:22am ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+24.67%
Earnings growth (this year)-35.10%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book5.51

Competitors

 Today’s
change
Today’s
% change
AVDLAvadel Pharmaceutica...-0.06-0.85%
IOVAIovance Biotherapeut...-0.18-1.31%
DEPODepomed Inc+0.06+0.84%
SVASinovac Biotech Ltd+0.04+0.50%
Data as of 10:23am ET, 06/18/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$0.00
Annual profit (last year)-$33.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
CFO, Secretary &
Principal Accounting Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts